Internal Medicine, Endocrinology, Diabetes, & Metabolism · Newport Beach, CA
NPI
1558357319
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
355 Placentia Ave, Ste 99
Newport Beach, CA, 92663
Phone (949) 650-0616
Groups this clinician bills Medicare through
Medicare paid, 2024
$183K
2,969 services
Medicare patients, 2024
361
Average age 74
Drug cost, 2024
$536K
1,757 prescriptions
Company payments, 2025
$8,510
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sean P Nikravan was code 99214 (office e&m - established), 861 times for 309 patients. In total Sean P Nikravan billed 2,969 services in 28 codes, and Medicare paid $183K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 861 | 309 | $91.06 | $78K |
| J0897 Injection, denosumab, 1 mg | Office | 662 | 11 | $19.82 | $13K |
| 99215 Office E&M - Established | Office | 310 | 136 | $123.72 | $38K |
| 76536 Ultrasound - Nonspecific | Office | 231 | 184 | $88.04 | $20K |
| 95251 Test - Miscellaneous | Office | 214 | 64 | $24.75 | $5,297 |
| 99204 Office E&M - New | Office | 46 | 46 | $113.82 | $5,235 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 40 | 40 | $131.13 | $5,245 |
| 10005 Other Organ Systems | Office | 27 | 25 | $104.05 | $2,809 |
| 76942 Ultrasound - Nonspecific | Office | 23 | 21 | $47.48 | $1,092 |
| 96372 Injection Administration | Office | 19 | 14 | $10.42 | $198 |
| 95250 Test - Miscellaneous | Office | 18 | 16 | $128.25 | $2,308 |
| 93000 Electrocardiogram | Office | 18 | 17 | $10.97 | $197 |
| 99205 Office E&M - New | Office | 15 | 15 | $135.04 | $2,026 |
| 76940 Digestive/Gastrointestinal | Office | 12 | 12 | $109.88 | $1,319 |
By year: 2022 $212K for 1,946 services; 2023 $258K for 3,135 services; 2024 $183K for 2,969 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sean P Nikravan prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 144 prescriptions and refills. In total Sean P Nikravan wrote 1,757 Medicare prescriptions that cost $536K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 144 | 164 | 19 | $171K |
| Synthroid Levothyroxine Sodium | 112 | 295 | 36 | $12K |
| Atorvastatin Calcium Generic | 100 | 271 | 24 | $1,132 |
| Levothyroxine Sodium Generic | 92 | 230 | 31 | $2,341 |
| Jardiance Empagliflozin | 72 | 134 | 14 | $76K |
| Metformin Hcl Er Metformin Hcl | 64 | 150 | 14 | $850 |
| Losartan Potassium Generic | 56 | 140 | 16 | $705 |
| Rosuvastatin Calcium Generic | 41 | 111 | 13 | $623 |
| Pioglitazone Hcl Generic | 41 | 110 | Under 11 | $411 |
| Olmesartan Medoxomil Generic | 41 | 73 | Under 11 | $612 |
| Amlodipine Besylate Generic | 38 | 86 | Under 11 | $269 |
| Metformin Hcl Generic | 36 | 85 | Under 11 | $410 |
| Allopurinol Generic | 31 | 45 | Under 11 | $53.75 |
| Repatha Sureclick Evolocumab | 30 | 48 | Under 11 | $27K |
| Xyosted Testosterone Enanthate | 29 | 38 | Under 11 | $23K |
Brand drugs: 727 claims; generic drugs: 1,000 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sean P Nikravan $8,510 ($8,510 in general payments such as food, travel and fees) from 24 companies. The largest payer was Cambridge Interventional LLC with $6,000.
| Company | Payments | Amount |
|---|---|---|
| Cambridge Interventional LLC | 1 | $6,000 |
| Antares Pharma, Inc. | 39 | $359 |
| Amgen Inc. AMGN | 17 | $326 |
| Ascendis Pharma Endocrinology Inc ASND | 10 | $248 |
| Novo Nordisk Inc NVO | 11 | $234 |
| Abbvie Inc. ABBV | 11 | $231 |
| Abbott Laboratories ABT | 13 | $223 |
| Recordati_rare_diseases_inc. | 7 | $150 |
| Lilly USA, LLC LLY | 4 | $109 |
| Corcept Therapeutics CORT | 4 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.